|
2004 Conference Publication RNA-loading of CMRF-56 positive blood dendritic cells is a promising strategy for multiple myeloma immunotherapyTurtle, C. J., Radford, K. J., Allan, C. P., Kassianos, A., Kato, M., Vuckovic, S., MacDonald, K.J., Lopez, Jose A., Jackson, D. C., Wright, S., Taylor, K., Marlton, P., Gill, D., Hart, D. N. J. and Korngold, R. (2004). RNA-loading of CMRF-56 positive blood dendritic cells is a promising strategy for multiple myeloma immunotherapy. Tandem BMT 2004 Meeting, Orlando, Florida, U.S., 13-17 February 2004. CHARLOTTESVILLE: AMER SOC HEMATOLOGY. doi: 10.1016/j.bbmt.2003.12.081 |
|
2004 Journal Article Potential therapeutic applications of recombinant, invasive E. coliCritchley, R, Jezzard, S, Radford, KJ, Goussard, S, Lemoine, NR, Grillot-Courvalin, C and Vassaux, G (2004). Potential therapeutic applications of recombinant, invasive E. coli. Gene Therapy, 11 (15), 1224-1233. doi: 10.1038/sj.gt.3302281 |
|
2003 Conference Publication RNA-loading of CMRF-56 positive blood dendritic cells is a promising strategy for multiple myeloma immunotherapy.Turtle, CJ, Radford, KJ, Allan, CP, Kato, M and Hart, DNJ (2003). RNA-loading of CMRF-56 positive blood dendritic cells is a promising strategy for multiple myeloma immunotherapy.. 45th Annual Meeting of the American-Society-of-Hematology, San Diego California, Dec 06-09, 2003. WASHINGTON: AMER SOC HEMATOLOGY. |
|
2003 Journal Article Recombinant E. coli efficiently delivers antigen and maturation signals to human dendritic cells: Presentation of MART1 to CD8+ T cellsRadford, KJ, Jackson, AM, Wang, JH, Vassaux, G and Lemoine, NR (2003). Recombinant E. coli efficiently delivers antigen and maturation signals to human dendritic cells: Presentation of MART1 to CD8+ T cells. International Journal of Cancer, 105 (6), 811-819. doi: 10.1002/ijc.11149 |
|
2002 Journal Article A recombinant E. coli vaccine to promote MHC class I-dependent antigen presentation: application to cancer immunotherapyRadford, K. J., Higgins, D. E., Pasquini, S., Cheadle, E. J., Carta, L., Jackson, A. M., Lemoine, N. R. and Vassaux, G. (2002). A recombinant E. coli vaccine to promote MHC class I-dependent antigen presentation: application to cancer immunotherapy. Gene Therapy, 9 (21), 1455-1463. doi: 10.1038/sj.gt.3301812 |
|
1997 Journal Article Immunogenicity of CD63 in a patient with melanomaSmith, Melanie, Bleijs, Rik, Radford, Kristen and Mersey, Peter (1997). Immunogenicity of CD63 in a patient with melanoma. Melanoma Research, 7 (SUPPL. 2) |
|
1997 Journal Article Regulation of tumor cell motility and migration by CD63 in a human melanoma cell lineRadford, KJ, Thorne, RF and Hersey, P (1997). Regulation of tumor cell motility and migration by CD63 in a human melanoma cell line. Journal of Immunology, 158 (7), 3353-3358. |
|
1996 Journal Article CD63 associates with transmembrane 4 superfamily members, CD9 and CD81, and with β1 integrins in human melanomaRadford, KJ, Thorne, RF and Hersey, P (1996). CD63 associates with transmembrane 4 superfamily members, CD9 and CD81, and with β1 integrins in human melanoma. Biochemical and Biophysical Research Communications, 222 (1), 13-18. doi: 10.1006/bbrc.1996.0690 |
|
1995 Journal Article Suppression of human melanoma cell growth and metastasis by the melanoma-associated antigen CD63 (ME491)Radford, KJ, Mallesch, J and Hersey, P (1995). Suppression of human melanoma cell growth and metastasis by the melanoma-associated antigen CD63 (ME491). International Journal of Cancer, 62 (5), 631-635. doi: 10.1002/ijc.2910620523 |
